Ingevity Balance Sheet Health
Financial Health criteria checks 1/6
Ingevity has a total shareholder equity of $214.5M and total debt of $1.4B, which brings its debt-to-equity ratio to 652.5%. Its total assets and total liabilities are $2.2B and $2.0B respectively. Ingevity's EBIT is $233.1M making its interest coverage ratio 2.6. It has cash and short-term investments of $135.5M.
Key information
652.5%
Debt to equity ratio
US$1.40b
Debt
| Interest coverage ratio | 2.6x |
| Cash | US$135.50m |
| Equity | US$214.50m |
| Total liabilities | US$2.00b |
| Total assets | US$2.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IGX's short term assets ($636.8M) exceed its short term liabilities ($360.8M).
Long Term Liabilities: IGX's short term assets ($636.8M) do not cover its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: IGX's net debt to equity ratio (589.4%) is considered high.
Reducing Debt: IGX's debt to equity ratio has increased from 280.2% to 652.5% over the past 5 years.
Debt Coverage: IGX's debt is not well covered by operating cash flow (7.9%).
Interest Coverage: IGX's interest payments on its debt are not well covered by EBIT (2.6x coverage).